Discovery MI Gen2 vs syngo MBF
AI Verdict
Choose Discovery MI Gen2 if…
Choose Discovery MI Gen2 if your institution requires a versatile, high-performance digital PET/CT system for comprehensive diagnostic imaging across oncology, neurology, and cardiology. This tool is ideal for scenarios demanding superior image quality, enhanced small lesion detectability, and efficient workflow through deep-learning AI reconstruction and advanced motion correction.
View Discovery MI Gen2 →Choose syngo MBF if…
Choose syngo MBF if your primary need is highly specialized, quantitative myocardial blood flow (MBF) analysis using PET imaging for cardiac diagnostics. This AI-enhanced software is best suited for cardiology departments focused on precise assessment of myocardial perfusion and flow reserve, offering advanced tools for therapy response evaluation and comparison against a normals database.
View syngo MBF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Discovery MI Gen2 | syngo MBF |
|---|---|---|
| Pricing | Starts at $15,500.00 | Contact vendor |
| Deployment | On-premise | On-premise (dedicated hardware), Virtualized environments (VMware, Hyper-V) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Discovery MI Gen2 | syngo MBF |
|---|---|---|
| Product Name | Discovery MI Gen2 | syngo MBF |
| Company | GE HealthCare | Siemens Medical Solutions USA, Inc. |
| Primary Function | Next-generation digital PET/CT system for diagnostic imaging in oncology, neurology, and cardiology. | AI-enhanced software for quantitative myocardial blood flow (MBF) analysis using PET imaging. |
| Key AI Feature | TrueFidelityu2122 deep-learning based image reconstruction | AI-powered Automatic Landmarking and Parsing of Human Anatomy (ALPHA) for workflow acceleration (via syngo.via platform) |
| Key Diagnostic Capability | Improved small lesion detectability (up to 41% increase), High sensitivity (up to 125% increase) | Quantitative Myocardial Blood Flow (MBF) and Myocardial Flow Reserve (MFR) calculation |
Videos
Demos, reviews, and walkthroughs featuring Discovery MI Gen2 and syngo MBF.